Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Iron Isomaltose Anhydride for Preoperative Anemia in Orthopedic Surgery
NCT03915327Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2024
- Primary completion
- May 2028
- Modality
- Inorganic Nanoparticles, Small Molecules
01
Overview
Randomised, open-label trial of ferric derisomaltose in iron deficiency anemia (IDA) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Rate of allogeneic red blood cell transfusion at 30 days. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03915327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03915327.